The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice

Birgitta Clinchy, Adi Gazdar, Rosalia Rabinovsky, Eitan Yefenof, Brian Gordon, Ellen S. Vitetta

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

HER-2/neu is overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for immunotherapy. To facilitate testing of anti-HER-2-monoclonal antibodies (MAbs) and immunotoxins (ITs), we have evaluated the in viva growth and metastatic spread of three HER-2-overexpressing human breast cancer cell lines (BT474, MDA-MB-453 and HCC1954) and one ovarian cancer cell line (SKOV3.ip1) in pre-irradiated male SCID mice using subcutaneous (s.c.), intravenous (i.v.) and intraperitoneal (i.p.) routes of injection. All the cell lines tested grew as s.c. tumors and the growth of BT474 and MDA-MB-453 cells after s.c. injection was improved by co-inoculation with Matrigel. Metastases to the lungs were detectable by PCR or histopathology after s.c. injection of BT474 and to a much lesser extent after s.c. injection of HCC1954, MD-MB-453 and SKOV3.ip1 cells. I.P. injection of HCC1954 and SKOV3.ip1 cells produced fatal ascites while i.v. injection of SKOV3.ip1, but not BT474 or MDA-MB-453 cells, resulted in infiltration of lungs and death within 9-11 weeks.

Original languageEnglish (US)
Pages (from-to)217-228
Number of pages12
JournalBreast Cancer Research and Treatment
Volume61
Issue number3
DOIs
StatePublished - 2000

Fingerprint

SCID Mice
Tumor Cell Line
Subcutaneous Injections
Neoplasm Metastasis
Growth
Cell Line
Immunotoxins
Lung
Intraperitoneal Injections
Ascites
Intravenous Injections
Ovarian Neoplasms
Immunotherapy
Adenocarcinoma
Monoclonal Antibodies
Breast Neoplasms
Polymerase Chain Reaction
Injections
Neoplasms

Keywords

  • Breast cancer
  • Her-2/neu
  • In vivo tumor models
  • Metastasis
  • SCID mice
  • Soluble Her-2

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice. / Clinchy, Birgitta; Gazdar, Adi; Rabinovsky, Rosalia; Yefenof, Eitan; Gordon, Brian; Vitetta, Ellen S.

In: Breast Cancer Research and Treatment, Vol. 61, No. 3, 2000, p. 217-228.

Research output: Contribution to journalArticle

Clinchy, Birgitta ; Gazdar, Adi ; Rabinovsky, Rosalia ; Yefenof, Eitan ; Gordon, Brian ; Vitetta, Ellen S. / The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice. In: Breast Cancer Research and Treatment. 2000 ; Vol. 61, No. 3. pp. 217-228.
@article{acc3fce7fb7241b6873ceb77fa92a46e,
title = "The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice",
abstract = "HER-2/neu is overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for immunotherapy. To facilitate testing of anti-HER-2-monoclonal antibodies (MAbs) and immunotoxins (ITs), we have evaluated the in viva growth and metastatic spread of three HER-2-overexpressing human breast cancer cell lines (BT474, MDA-MB-453 and HCC1954) and one ovarian cancer cell line (SKOV3.ip1) in pre-irradiated male SCID mice using subcutaneous (s.c.), intravenous (i.v.) and intraperitoneal (i.p.) routes of injection. All the cell lines tested grew as s.c. tumors and the growth of BT474 and MDA-MB-453 cells after s.c. injection was improved by co-inoculation with Matrigel. Metastases to the lungs were detectable by PCR or histopathology after s.c. injection of BT474 and to a much lesser extent after s.c. injection of HCC1954, MD-MB-453 and SKOV3.ip1 cells. I.P. injection of HCC1954 and SKOV3.ip1 cells produced fatal ascites while i.v. injection of SKOV3.ip1, but not BT474 or MDA-MB-453 cells, resulted in infiltration of lungs and death within 9-11 weeks.",
keywords = "Breast cancer, Her-2/neu, In vivo tumor models, Metastasis, SCID mice, Soluble Her-2",
author = "Birgitta Clinchy and Adi Gazdar and Rosalia Rabinovsky and Eitan Yefenof and Brian Gordon and Vitetta, {Ellen S.}",
year = "2000",
doi = "10.1023/A:1006494001861",
language = "English (US)",
volume = "61",
pages = "217--228",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice

AU - Clinchy, Birgitta

AU - Gazdar, Adi

AU - Rabinovsky, Rosalia

AU - Yefenof, Eitan

AU - Gordon, Brian

AU - Vitetta, Ellen S.

PY - 2000

Y1 - 2000

N2 - HER-2/neu is overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for immunotherapy. To facilitate testing of anti-HER-2-monoclonal antibodies (MAbs) and immunotoxins (ITs), we have evaluated the in viva growth and metastatic spread of three HER-2-overexpressing human breast cancer cell lines (BT474, MDA-MB-453 and HCC1954) and one ovarian cancer cell line (SKOV3.ip1) in pre-irradiated male SCID mice using subcutaneous (s.c.), intravenous (i.v.) and intraperitoneal (i.p.) routes of injection. All the cell lines tested grew as s.c. tumors and the growth of BT474 and MDA-MB-453 cells after s.c. injection was improved by co-inoculation with Matrigel. Metastases to the lungs were detectable by PCR or histopathology after s.c. injection of BT474 and to a much lesser extent after s.c. injection of HCC1954, MD-MB-453 and SKOV3.ip1 cells. I.P. injection of HCC1954 and SKOV3.ip1 cells produced fatal ascites while i.v. injection of SKOV3.ip1, but not BT474 or MDA-MB-453 cells, resulted in infiltration of lungs and death within 9-11 weeks.

AB - HER-2/neu is overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for immunotherapy. To facilitate testing of anti-HER-2-monoclonal antibodies (MAbs) and immunotoxins (ITs), we have evaluated the in viva growth and metastatic spread of three HER-2-overexpressing human breast cancer cell lines (BT474, MDA-MB-453 and HCC1954) and one ovarian cancer cell line (SKOV3.ip1) in pre-irradiated male SCID mice using subcutaneous (s.c.), intravenous (i.v.) and intraperitoneal (i.p.) routes of injection. All the cell lines tested grew as s.c. tumors and the growth of BT474 and MDA-MB-453 cells after s.c. injection was improved by co-inoculation with Matrigel. Metastases to the lungs were detectable by PCR or histopathology after s.c. injection of BT474 and to a much lesser extent after s.c. injection of HCC1954, MD-MB-453 and SKOV3.ip1 cells. I.P. injection of HCC1954 and SKOV3.ip1 cells produced fatal ascites while i.v. injection of SKOV3.ip1, but not BT474 or MDA-MB-453 cells, resulted in infiltration of lungs and death within 9-11 weeks.

KW - Breast cancer

KW - Her-2/neu

KW - In vivo tumor models

KW - Metastasis

KW - SCID mice

KW - Soluble Her-2

UR - http://www.scopus.com/inward/record.url?scp=0033868727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033868727&partnerID=8YFLogxK

U2 - 10.1023/A:1006494001861

DO - 10.1023/A:1006494001861

M3 - Article

C2 - 10965998

AN - SCOPUS:0033868727

VL - 61

SP - 217

EP - 228

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -